What is the International Conference on Harmonisation (ICH)?
The International Conference on Harmonisation (ICH) is a unique project that brings together the regulatory authorities and pharmaceutical industry of Europe, Japan, and the United States. It aims to ensure that the development and registration of new medicinal products occur in the most efficient manner while maintaining high standards of safety, quality, and efficacy. In the context of cancer, the ICH guidelines play a crucial role in streamlining the research, development, and approval processes for new oncological treatments.
